GlassScriptPhysician profile
Trevor R Williams
NPI 1881642676
$42,076.31
in general payments reported to CMS, 2019-2025
26 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,286 · 2020: $4,431 · 2021: $10K · 2022: $12K · 2023: $5,989 · 2024: $136 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Travel and Lodging: $1,063 · Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Travel and Lodging | $1,063.07 |
| Food and Beverage | $1,017.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $40,003.36 | 2019-2025 | Trueshot, Biobrace 23mm, Colink Plating System |
| Zimmer Biomet Holdings, INC. | $613.61 | 2019 | |
| Treace Medical Concepts, INC. | $363.31 | 2022-2025 | |
| Abbott Laboratories | $209.65 | 2021-2022 | |
| Stryker Corporation | $200.03 | 2019-2024 | Citrefix |
| Paragon 28, INC. | $139.25 | 2025 | Precision Mis Bunion |
| Celularity INC. | $92.00 | 2019 | |
| Medtronic Vascular, INC. | $90.26 | 2019 | |
| Dynasplint Systems INC. | $40.50 | 2021 | |
| Horizon Therapeutics Plc | $31.64 | 2019 | |
| Abbvie INC. | $31.14 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $29.29 | 2023 | Nuzyra |
| Innovation Technologies INC | $28.74 | 2024 | Irrisept |
| Arthrosurface Incorporated | $24.23 | 2019-2020 | |
| Anika Therapeutics, INC. | $19.35 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $18.70 | 2022 | |
| Amgen INC. | $18.57 | 2025 | Krystexxa |
| Acell, INC. | $15.76 | 2020 | |
| Ani Pharmaceuticals, INC. | $15.43 | 2025 | Purified Cortrophin Gel |
| Biocomposites INC | $14.81 | 2024 | |
| Heron Therapeutics, INC. | $14.60 | 2021 | |
| Allergan, INC. | $13.06 | 2019 | |
| Bioventus LLC | $12.83 | 2022 | |
| Smith+Nephew, INC. | $12.62 | 2021 | |
| Organogenesis INC. | $12.55 | 2022 | |
| Wright Medical Technology, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.